BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7274985)

  • 1. [Enhancement of the antitumor transplantation resistance in rats by the antileukemia drug busulfan (author's transl)].
    Mizushima Y
    Hokkaido Igaku Zasshi; 1980 Nov; 55(6):537-42. PubMed ID: 7274985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan.
    Mizushima Y; Sendo F; Takeichi N; Hosohawa M; Kobayashi H
    Cancer Res; 1981 Jul; 41(7):2917-21. PubMed ID: 6454480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enhanced immunogenicity of xenogenized tumor cells in rats pretreated with cyclophosphamide (author's transl)].
    Terashima M
    Hokkaido Igaku Zasshi; 1980 Nov; 55(6):495-9. PubMed ID: 6456215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic effect of the antileukemia drug busulfan as an immunomodulator on transplanted fibrosarcoma KMT-17 in WKA rats.
    Mizushima Y; Koga Y; Yuhki N; Kobayashi H
    Gan; 1983 Feb; 74(1):162-8. PubMed ID: 6840435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
    Mizushima Y; Sendo F; Miyake T; Kobayashi H
    J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic potential of tumor cells after treatment with antitumor chemotherapeutic agents.
    Ujiie T
    Jpn J Exp Med; 1988 Feb; 58(1):33-8. PubMed ID: 2454340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune mechanisms in leukemia: suppression of cellular immunity by drugs and x-irradiation.
    Martinez D; Lukasewycz OA; Murphy WH
    J Immunol; 1975 Sep; 115(3):724-9. PubMed ID: 1151076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies and progress on the enhancement of therapeutic effects of antitumor drugs].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1107-15. PubMed ID: 6408997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the immuno-suppressive effects of adriamycin and tumor metastasis (author's transl)].
    Chang S; Toida S; Abe M; Hayashi M
    Nihon Seikeigeka Gakkai Zasshi; 1980 Jul; 54(7):677-84. PubMed ID: 7009766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 11. [Augmentation of specific anti-tumor immunity by immunization with xenogenized tumor cells and its application to the experimental cancer treatment (author's transl)].
    Okayasu T
    Hokkaido Igaku Zasshi; 1981 Nov; 56(6):615-22. PubMed ID: 7338338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological response modifying effect of chemotherapeutic agents against cancer].
    Ogura T
    Gan To Kagaku Ryoho; 1984 May; 11(5):965-73. PubMed ID: 6232899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxazaphosphorine effects in L 5222 rat leukemia.
    Pohl J; Reissmann T; Voegeli R
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):589-94. PubMed ID: 3437788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antitumor effect of cyclophosphamide by centrophenoxine.
    Kanzawa F; Hoshi A; Kuretani K
    Gan; 1971 Jun; 62(3):235-6. PubMed ID: 4398065
    [No Abstract]   [Full Text] [Related]  

  • 15. Metallothionein-mediated resistance to multiple drugs can be induced by several anticancer drugs in mice.
    Okazaki Y; Miura N; Satoh M; Imura N; Naganuma A
    Biochem Biophys Res Commun; 1998 Apr; 245(3):815-8. PubMed ID: 9588197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capability of adriamycin and busulfan to induce adaptive response in vitro.
    Anuszewska EL; Koziorowska JH
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):51-4. PubMed ID: 11729829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of regression of virally xenogenized tumor cells by cyclophosphamide and busulfan.
    Morikawa K; Hamada J; Itaya T; Ishikawa M; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Immunol Immunother; 1988; 26(1):18-22. PubMed ID: 3345537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anticancer drugs on the immune system in humans.
    Ehrke MJ; Mihich E; Berd D; Mastrangelo MJ
    Semin Oncol; 1989 Jun; 16(3):230-53. PubMed ID: 2658084
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous regression of syngeneic transplanted tumors in rats pretreated with the antileukemia drug busulfan.
    Sendo F; Miyake T; Fuyama S; Arai S
    J Natl Cancer Inst; 1978 Feb; 60(2):385-9. PubMed ID: 621755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.